Opening book details…
About this Medicine article
Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members by van Luijn, H. E. M.; Musschenga, A. W.; Keus, R. B.; Robinson, W. M.; Aaronson, N. K. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- van Luijn, H. E. M.; Musschenga, A. W.; Keus, R. B.; Robinson, W. M.; Aaronson, N. K.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2002
- Language
- EN
- Field
- Medicine (Health Sciences)